Invesco’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$877K Buy
113,570
+10,454
+10% +$76.3K ﹤0.01% 2926
2025
Q4
$632K Buy
103,116
+38,626
+60% +$417K ﹤0.01% 3117
2025
Q3
$1.19M Buy
64,490
+19,629
+44% +$315K ﹤0.01% 2849
2025
Q2
$584K Buy
44,861
+9,965
+29% +$118K ﹤0.01% 3093
2025
Q1
$370K Buy
34,896
+15,836
+83% +$251K ﹤0.01% 3280
2024
Q4
$323K Buy
19,060
+225
+1% +$4.24K ﹤0.01% 3390
2024
Q3
$437K Buy
18,835
+156
+0.8% +$3.34K ﹤0.01% 3292
2024
Q2
$455K Sell
18,679
-1,273
-6% -$38.6K ﹤0.01% 3309
2024
Q1
$674K Buy
19,952
+6,696
+51% +$237K ﹤0.01% 3188
2023
Q4
$418K Sell
13,256
-120,315
-90% -$2.86M ﹤0.01% 3311
2023
Q3
$3.41M Buy
133,571
+122,953
+1,158% +$3.79M ﹤0.01% 2394
2023
Q2
$305K Buy
10,618
+734
+7% +$20K ﹤0.01% 3492
2023
Q1
$237K Sell
9,884
-15,462
-61% -$277K ﹤0.01% 3576
2022
Q4
$430K Sell
25,346
-988
-4% -$17.2K ﹤0.01% 3346
2022
Q3
$391K Buy
26,334
+177
+0.7% +$2.97K ﹤0.01% 3378
2022
Q2
$412K Buy
26,157
+4,417
+20% +$86.7K ﹤0.01% 3431
2022
Q1
$586K Buy
21,740
+13,473
+163% +$344K ﹤0.01% 3308
2021
Q4
$306K Sell
8,267
-1,326
-14% -$54K ﹤0.01% 3604
2021
Q3
$459K Buy
9,593
+839
+10% +$37.6K ﹤0.01% 3468
2021
Q2
$295K Buy
8,754
+3,079
+54% +$104K ﹤0.01% 3635
2021
Q1
$234K Buy
+5,675
New +$338K ﹤0.01% 3641
2020
Q4
Sell
-8,414
Closed -$362K 3769
2020
Q3
$362K Sell
8,414
-212,490
-96% -$10.5M ﹤0.01% 3248
2020
Q2
$10.3M Buy
+220,904
New +$7.61M ﹤0.01% 1611

Other funds holding ARCT